Table 2.
Clinical performance characteristics
| Detection of Any Cancer at Biopsy | ||
|---|---|---|
| Parameter | Value | 95% CI |
| Sensitivity | 74.1% | 63.1%−83.1% |
| Specificity | 60.0% | 51.1%−68.5% |
| Disease prevalence | 38.4% | N/A |
| PPV | 53.6% | 47.4%−59.6% |
| NPV | 78.8% | 71.5%−84.6% |
|
| ||
| Detection of High-grade Cancer at Biopsy | ||
|
| ||
| Sensitivity | 77.8% | 57.7%−91.4% |
| Specificity | 52.7% | 45.2%−60.1% |
| Disease prevalence | 12.8% | N/A |
| PPV | 19.4% | 15.8%−23.7% |
| NPV | 94.2% | 88.7%−97.1% |
CI, confidence interval; NPV, negative predictive value; PPV, positive predictive value.